Milestone Pharmaceuticals Inc.
MIST
$1.07
-$0.06-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 559.00K | 238.00K | 1.55M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 559.00K | 238.00K | 1.55M | -- | -- |
| Cost of Revenue | 32.00K | 14.00K | -- | -- | -- |
| Gross Profit | 527.00K | 224.00K | 1.55M | -- | -- |
| SG&A Expenses | 22.65M | 20.64M | 13.28M | 7.89M | 8.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.19M | 23.90M | 18.80M | 11.83M | 12.53M |
| Operating Income | -25.63M | -23.66M | -17.26M | -11.83M | -12.53M |
| Income Before Tax | -28.61M | -26.07M | -17.41M | -11.92M | -12.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.61M | -26.07M | -17.41M | -11.92M | -12.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.61M | -26.07M | -17.41M | -11.92M | -12.97M |
| EBIT | -25.63M | -23.66M | -17.26M | -11.83M | -12.53M |
| EBITDA | -25.57M | -23.61M | -17.22M | -11.80M | -12.50M |
| EPS Basic | -0.21 | -0.20 | -0.16 | -0.12 | -0.20 |
| Normalized Basic EPS | -0.13 | -0.13 | -0.10 | -0.08 | -0.12 |
| EPS Diluted | -0.21 | -0.20 | -0.16 | -0.12 | -0.20 |
| Normalized Diluted EPS | -0.13 | -0.13 | -0.10 | -0.08 | -0.12 |
| Average Basic Shares Outstanding | 138.69M | 130.29M | 106.04M | 96.49M | 66.38M |
| Average Diluted Shares Outstanding | 138.69M | 130.29M | 106.04M | 96.49M | 66.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |